Intraportal injection of specific allogeneic cells can prolong neonatal intestinal free graft survival.
Lee
S K
SK
Department of Surgery, Children's Hospital, Boston, MA 02115.
Perez-Atayde
A
A
Takeda
T
T
Vacanti
J P
JP
Lund
D P
DP
D000818:Animals; D000831:Animals, Newborn; D016572:Cyclosporine / Q000627:therapeutic use; D006084:Graft Rejection / Q000276:immunology / Q000517:prevention & control*; D006085:Graft Survival / Q000276:immunology*; D007165:Immunosuppression Therapy / Q000379:methods*; D007275:Injections, Intravenous; D007421:Intestine, Small / Q000637:transplantation*; D016031:Liver Transplantation / Q000276:immunology*; D017710:Lymphocyte Transfusion; D011169:Portal Vein; D051381:Rats; D011914:Rats, Inbred BN; D011917:Rats, Inbred Lew; D011920:Rats, Inbred WF; D013997:Time Factors; D014184:Transplantation, Homologous / Q000276:immunology
D016572:Cyclosporine